Searched for
PSORIASIS TREATMENT
Sun Pharma sees steady FY27 growth, progresses $11.75 bn Organon integration dealSun Pharma anticipates strong growth in the coming years. The company expects a high single-digit increase in its overall sales by FY2027. ...- Sun Pharma shares jump over 9% after firm announces $12 billion Organon acquisitionSun Pharmaceutical Industries' shares surged after announcing the $11.75 billion acquisition of US-based Organon & Co., a global leader in ...
- ET Exclusive | Sun Pharma set to acquire Organon for $12.5 bn, its biggest till dateUS company’s board meeting is happening this weekend to finalise decision; an announcement is imminent later tonight or by Monday. Mumbai H...
- Alembic Pharma gets USFDA nod for generic cancer, arthritis injectionAlembic Pharmaceuticals has received final approval from the US Food and Drug Administration for its generic methotrexate injection, used t...
- 31-year-old suffered from rare immune condition, could barely do his job, shares the one habit which helped him healA 31-year-old man's psoriasis severely worsened after COVID-19, leading to significant weight loss and emotional distress. He found relief ...
- Sun Pharma launches Ilumya for psoriasis treatment in IndiaSun Pharmaceutical Industries has launched its innovative drug Ilumya in India. This medication treats moderate-to-severe plaque psoriasis....
- Sun Pharma brings global psoriasis drug ILUMYA to Indian marketSun Pharmaceutical Industries has launched its innovative biologic drug, ILUMYA, in India for moderate-to-severe plaque psoriasis. This nov...
- Unichem Laboratories gets USFDA nod for plaque psoriasis treatment drugApremilast tablets are indicated for the treatment of adult patients with moderate to severe plaque psoriasis who are candidates for photot...
- Sun Pharma arm launches plaque psoriasis treatment drug in JapanIn a regulatory filing, Sun Pharmaceutical Industries said its "wholly-owned Japanese subsidiary has launched Ilumya Subcutaneous Injection...
- New psoriasis drug study yields positive results: Dr Reddy'sAccording to a press release from the city-based drug-maker, the detailed safety and efficacy data from the study would be presented in fut...
- Lupin launches plaque psoriasis treatment spray in US marketQuoting IQVIA MAT May 2018 data, Lupin said Desoximetasone Topical Spray, 0.25 per cent, had annual sales of approximately USD 18.7 million...
- Lupin gets USFDA nod for generic psoriasis treatment solutionThe USFDA approval to Lupin's calcipotriene topical solution is for strength of 0.005 per cent (scalp solution), the company said in a stat...
- Glenmark launches oral drug for Psoriasis treatment in IndiaThe Mumbai-based company has launched Apremilast under the brand name Aprezo. It has received approval from DCGI for Apremilast after condu...
- US FDA accepts application for psoriasis drug: Sun PharmaThe FDA filing acceptance follows the acceptance of the regulatory filing of tildrakizumab by the European Medicines Agency (EMA) in March ...
- Novartis Healthcare launches psoriasis treatment drug in IndiaNovartis Healthcare has launched secukinumab, used for the treatment of plaque psoriasis in adult patients, in India. The company has launc...
- GVK Bio, Akaal Pharma extend partnership for drug developmentGVK Biosciences was under the regulatory scanner of European drug regulators a few months ago.
- Biocon seeking partners to develop, market psoriasis drugBiotechnology major Biocon today said it is looking for partners to develop and market its novel biologic drug Itolizumab
- Biocon to launch psoriasis drug novel biologic in JulyThe company had received marketing authorisation for Itolizumab from the Drugs Controller General of India (DCGI) in January, 2013.
- Biocon gets DCGI approval to market anti-psoriasis drug, Itolizumab"The company has received market authorisation from the DCGI for its novel biologic Itolizumab, for treatment of chronic plaque psoriasis,"...
- Govt to share Lupin's migraineThe government's Department of Science and Technology (DST) has committed over Rs 10 crore to support drug maker Lupin's two clinical devel...
Load More
